## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `article_bundle` — **LLM article bundle**
Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution.
- **article slug:** `tesamorelin-ppis`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Reference block for Grok/GPT/Gemini. Section §SELF explains the system.
- **read:** https://miscsubjects.com/api/articles/tesamorelin-ppis/bundle?format=markdown

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/tesamorelin-ppis/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/tesamorelin-ppis/topology
- **voxels** — Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance. · https://miscsubjects.com/api/articles/tesamorelin-ppis/voxels
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/tesamorelin-ppis/prompts
- **ingest** — Parse pasted evidence → source ledger + claims + evidence_ingest node.
- **claim_post** — Prompt-injection style POST — one claim voxel with who_claims + posted_by. · https://miscsubjects.com/api/articles/tesamorelin-ppis/voxels
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*

---

# miscsubjects article bundle

> Reference bundle for Grok, GPT, Gemini, or a human reader. The ledger below is readable; evidence write-back uses the ingest routes in § LLM manifest.

## MASTHEAD
- **identity:** `tesamorelin-ppis` v2 · content_hash `cd8844ff06a789a9…` · thread_head genesis · 24 DIVs
- **thesis (c1):** Long-term PPI use is associated with increased risk of nutrient deficiencies including B12, magnesium, and calcium.
  - c2 [human/active] Tesamorelin reduces visceral adipose tissue by 18% over 12 months in a human trial of 404 HIV patients.
  - c3 [human/active] Meta-analysis shows tesamorelin reduces visceral fat, trunk fat, and hepatic fat while increasing lean mass in HIV lipodystrophy (human RCTs).
  - c5 [human/active] Observational studies associate long-term PPI use with higher fracture risk via nutrient absorption interference.
  - c4 [mechanistic/active] No direct human trials or interaction data link tesamorelin to PPIs or their side effects.
- **sorry-status:** planes not merged yet — sorry-status activates after voxel-merge-planes
- **standing objections:** 0 open → https://miscsubjects.com/api/articles/tesamorelin-ppis/discourse
- **verbs:** read free · challenge/attest open · edit/move/consolidate CAS-gated with a rows:VOXEL_* key
- **reads_next:** https://miscsubjects.com/a/philosophy · https://miscsubjects.com/api/articles/tesamorelin-ppis/discourse · https://miscsubjects.com/api/protocol

## Article
- **slug:** `tesamorelin-ppis`
- **title:** Tesamorelin and PPIs: Evidence Review on GH Axis Effects and Long-Term Acid Suppression
- **url:** https://miscsubjects.com/a/tesamorelin-ppis
- **register:** source_ledger
- **updated:** 2026-07-17T02:42:25.706Z
- **tags:** peptide, matrix

## Body

## What's breaking down if you have PPIs (omeprazole, etc.)

Long-term PPI use suppresses stomach acid production. This reduces symptoms of acid reflux but alters nutrient absorption over months or years. Key layers affected include calcium, magnesium, vitamin B12, and iron uptake. Reduced acid can also change gut microbiome balance and raise infection risks.

If your bone density declines or muscle recovery slows, the chain often traces back to these absorption changes. PPIs do not directly damage tissue but limit the raw materials the body needs for ongoing repair.

## Why Tesamorelin might help you

1. You are reading about PPIs — acid suppression creates downstream nutrient gaps that can affect metabolism and tissue maintenance.
2. Therefore for you: If visceral fat accumulation or reduced lean mass is part of your profile alongside PPI use, Tesamorelin is discussed because it stimulates endogenous growth hormone release that targets fat breakdown and supports lean tissue — not because it restores stomach acid or replaces missing nutrients.

Tesamorelin acts on the GH axis. Higher GH and IGF-1 levels promote lipolysis in visceral fat stores. This may indirectly ease metabolic load. No data shows it reverses PPI-induced nutrient shortfalls.

## Why PPIs (omeprazole, etc.) matters for you

Drug: PPIs (omeprazole, etc.)
What it does: Acid suppression; long-term mucosal and nutrient consequences.
Therefore for you: This drug suppresses a signal (gastric acid) to control symptoms. It trades off repair pathways by limiting mineral and vitamin absorption, which can compound degeneration in bone and muscle over time rather than supporting them.

## How these fit together

Single-compound focus. Tesamorelin targets the GH axis and visceral fat layer. PPIs handle acid-related symptoms but introduce absorption trade-offs. The two operate on separate systems. Any overlap would require separate monitoring of nutrient status and body composition changes.

## What the evidence actually shows

Human trials of tesamorelin focus on HIV-associated lipodystrophy. One 12-month study with 404 patients showed 18% visceral fat reduction versus placebo (human tier). A meta-analysis of randomized trials confirmed reductions in visceral adipose tissue, trunk fat, and hepatic fat with increases in lean body mass (human tier).

No human trials examine tesamorelin with PPIs. Interaction checkers list moderate interactions for tesamorelin but none specific to common PPIs (mechanistic tier).

PPI long-term effects: Observational data link use beyond one year to higher fracture risk and deficiencies in B12, magnesium, and calcium (human tier, observational). FDA warnings note possible bone fracture increase with high-dose or prolonged use.

## What scientists say

Researchers note tesamorelin reliably lowers visceral fat and raises IGF-1 in targeted populations without major glucose disruption (human data from HIV studies). They emphasize the need for more data outside HIV. PPI researchers highlight absorption interference as the main mechanism for nutrient and bone concerns, calling for shortest effective duration.

## What people say on Reddit

Discussions on PPI side effects center on nutrient concerns and rebound symptoms. No widespread mentions pair tesamorelin specifically with PPIs. Users often discuss monitoring B12 and magnesium while on long-term PPIs (anecdotal tier).

## What people say on X

No public posts directly linking tesamorelin and PPIs appear in searches. General conversations on tesamorelin focus on body composition changes in approved contexts (anecdotal tier).

## What we do not know

No clinical data exist on tesamorelin altering PPI side effects or nutrient absorption. Effects on bone density in non-HIV users remain unstudied. Long-term outcomes beyond one year for tesamorelin are limited.

## Safety and limits

Tesamorelin carries injection-site reactions, arthralgia, and myalgia in trials. It is approved only for specific visceral fat reduction. PPIs require medical oversight for duration. Monitor nutrient levels and bone health independently of either compound. This is evidence review only, not guidance.

## Claims (5)

- **c2** [human w=0.8] Tesamorelin reduces visceral adipose tissue by 18% over 12 months in a human trial of 404 HIV patients.
  - who_claims: grok/grok-4.3
  - sources: s13
- **c1** [human w=0.8] Long-term PPI use is associated with increased risk of nutrient deficiencies including B12, magnesium, and calcium.
  - who_claims: grok/grok-4.3
  - sources: s0
- **c3** [human w=0.8] Meta-analysis shows tesamorelin reduces visceral fat, trunk fat, and hepatic fat while increasing lean mass in HIV lipodystrophy (human RCTs).
  - who_claims: grok/grok-4.3
  - sources: s14
- **c5** [human w=0.8] Observational studies associate long-term PPI use with higher fracture risk via nutrient absorption interference.
  - who_claims: grok/grok-4.3
  - sources: s0
- **c4** [mechanistic w=0.3] No direct human trials or interaction data link tesamorelin to PPIs or their side effects.
  - who_claims: grok/grok-4.3
  - sources: s2

## Voxel graph (5 atoms · 10 edges)
- full graph: https://miscsubjects.com/api/articles/tesamorelin-ppis/voxels

## Article constitution

- full: https://miscsubjects.com/api/articles/constitution

## Source ledger (4)
- chain valid: yes · head: `c622f32ee94bfaea`

### s0 · pubmed · ok
- title: Adverse Effects Associated with Proton Pump Inhibitor Use
- url: https://pmc.ncbi.nlm.nih.gov/articles/PMC7887997/
- summary: Review of long-term PPI adverse effects including nutrient malabsorption and infection risks.
- quote: impaired absorption of nutrients... increased risk of kidney, liver, and cardiovascular disease, dementia, enteroendocrine tumors... susceptibility to respiratory and gastrointestinal infections
- claim_ids: c1, c5
- hash: `6c49f7ebb9772474`

### s2 · other · http_403
- title: Tesamorelin Interactions Checker
- url: https://www.drugs.com/drug-interactions/tesamorelin.html
- summary: Lists interactions but no specific PPI mentions in summary.
- quote: There are 49 drugs known to interact with tesamorelin, along with 3 disease interactions. Of the total drug interactions, 49 are moderate.
- claim_ids: c4
- hash: `aed4ccdebf9753fe`

### s13 · pubmed · ok
- title: Tesamorelin Peptide | Benefits, Safety, & Buying Advice
- url: https://www.innerbody.com/tesamorelin
- summary: Summarizes key human trial results for visceral fat reduction.
- quote: In a 12-month clinical trial published in 2010, which involved 404 HIV-infected patients with excess abdominal fat, the group that received 2mg of tesamorelin per day saw an 18% decrease in visceral fat compared to placebo.
- claim_ids: c2
- hash: `70d2eb7e544258a1`

### s14 · pubmed · ok
- title: A meta-analysis of randomized controlled trials
- url: https://pubmed.ncbi.nlm.nih.gov/41545261/
- summary: Meta-analysis of tesamorelin RCTs in HIV lipodystrophy.
- quote: Tesamorelin was associated with significant reduction in visceral adipose tissue (MD=-27.71 cm²... increase in lean body mass (MD=1.42 kg...
- claim_ids: c3
- hash: `c622f32ee94bfaea`

## Provenance (2 model passes)
- chain valid: yes · head: `aa2b1667f7d3da26`

- write · grok/grok-4.3 · 2026-06-29T23:14 · hash `d4959a2d592b`
- voxel_divide · owner · 2026-07-17T02:42 · hash `aa2b1667f7d3`

## Question graph
- questions: 0 · evidence ingests: 0

## LLM manifest — how to communicate with this ledger

- system map: https://miscsubjects.com/api/articles/system-map?format=markdown
- topology (ranked): https://miscsubjects.com/api/articles/tesamorelin-ppis/topology
- ingest: POST https://miscsubjects.com/api/protocol/ingest
- claim: POST https://miscsubjects.com/api/protocol/claim

### Quick actions for this article
- **Read live:** https://miscsubjects.com/api/articles/tesamorelin-ppis/topology
- **Ask (API):** POST https://miscsubjects.com/api/protocol/ask `{"slug":"tesamorelin-ppis","question":"..."}`
- **Ingest your findings:** POST https://miscsubjects.com/api/protocol/ingest or text `ingest tesamorelin-ppis|your evidence`
- **Post one claim:** POST https://miscsubjects.com/api/protocol/claim or text `claim tesamorelin-ppis|tier|assertion`
- **iMessage ask:** `tesamorelin-ppis|your question`
- **System map:** https://miscsubjects.com/api/articles/system-map?format=markdown


---

## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `system_map` — **System map**
Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **article slug:** `tesamorelin-ppis`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **read:** https://miscsubjects.com/api/articles/system-map

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/tesamorelin-ppis/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **constitution** — Binding rules: required article slots, claim/source rules, ontology anti-sprawl. · https://miscsubjects.com/api/articles/constitution
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest
- **oip_article_hub** — Public article-native Object Invocation Protocol docs: /a/oip root, generated shelf/system/capability articles, machine bundles, token boundary, and receipt loop. · https://miscsubjects.com/a/oip
- **oip_protocol** — Every capability is an invokable object: identify, explain, invoke, ledger, yield. · https://miscsubjects.com/a/oip
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/tesamorelin-ppis/bundle?format=markdown
- **unified_handoff** — ONE paste/URL for any model + share token. Same self-explaining pattern as article bundle, but whole build. · https://miscsubjects.com/api/handoff?format=markdown

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*